These findings suggest that susceptibility alterations emerge after cardiac surgery and are linked to poorer developmental outcomes. Source-separated QSM may serve as a sensitive biomarker of brain tissue alterations and neurodevelopmental risk in newborns with CHD.
Jang et al. (Mon,) studied this question.